An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 180
Summary
- Conditions
- Alport Syndrome
- Autosomal Dominant Polycystic Kidney
- Chronic Kidney Diseases
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 12 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03749447
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon